140 related articles for article (PubMed ID: 36587182)
1. Chromatin remodeler CHD7 targets active enhancer region to regulate cell type-specific gene expression in human neural crest cells.
Sanosaka T; Okuno H; Mizota N; Andoh-Noda T; Sato M; Tomooka R; Banno S; Kohyama J; Okano H
Sci Rep; 2022 Dec; 12(1):22648. PubMed ID: 36587182
[TBL] [Abstract][Full Text] [Related]
2. Chromatin remodeler CHD7 regulates the stem cell identity of human neural progenitors.
Chai M; Sanosaka T; Okuno H; Zhou Z; Koya I; Banno S; Andoh-Noda T; Tabata Y; Shimamura R; Hayashi T; Ebisawa M; Sasagawa Y; Nikaido I; Okano H; Kohyama J
Genes Dev; 2018 Jan; 32(2):165-180. PubMed ID: 29440260
[TBL] [Abstract][Full Text] [Related]
3. CHD7 cooperates with PBAF to control multipotent neural crest formation.
Bajpai R; Chen DA; Rada-Iglesias A; Zhang J; Xiong Y; Helms J; Chang CP; Zhao Y; Swigut T; Wysocka J
Nature; 2010 Feb; 463(7283):958-62. PubMed ID: 20130577
[TBL] [Abstract][Full Text] [Related]
4. CHARGE syndrome modeling using patient-iPSCs reveals defective migration of neural crest cells harboring CHD7 mutations.
Okuno H; Renault Mihara F; Ohta S; Fukuda K; Kurosawa K; Akamatsu W; Sanosaka T; Kohyama J; Hayashi K; Nakajima K; Takahashi T; Wysocka J; Kosaki K; Okano H
Elife; 2017 Nov; 6():. PubMed ID: 29179815
[TBL] [Abstract][Full Text] [Related]
5. Sema3a plays a role in the pathogenesis of CHARGE syndrome.
Ufartes R; Schwenty-Lara J; Freese L; Neuhofer C; Möller J; Wehner P; van Ravenswaaij-Arts CMA; Wong MTY; Schanze I; Tzschach A; Bartsch O; Borchers A; Pauli S
Hum Mol Genet; 2018 Apr; 27(8):1343-1352. PubMed ID: 29432577
[TBL] [Abstract][Full Text] [Related]
6. CHD7 regulates cardiovascular development through ATP-dependent and -independent activities.
Yan S; Thienthanasit R; Chen D; Engelen E; Brühl J; Crossman DK; Kesterson R; Wang Q; Bouazoune K; Jiao K
Proc Natl Acad Sci U S A; 2020 Nov; 117(46):28847-28858. PubMed ID: 33127760
[No Abstract] [Full Text] [Related]
7. CHD7, the gene mutated in CHARGE syndrome, regulates genes involved in neural crest cell guidance.
Schulz Y; Wehner P; Opitz L; Salinas-Riester G; Bongers EM; van Ravenswaaij-Arts CM; Wincent J; Schoumans J; Kohlhase J; Borchers A; Pauli S
Hum Genet; 2014 Aug; 133(8):997-1009. PubMed ID: 24728844
[TBL] [Abstract][Full Text] [Related]
8. Sema3E is required for migration of cranial neural crest cells in zebrafish: Implications for the pathogenesis of CHARGE syndrome.
Liu ZZ; Guo J; Lu Y; Liu W; Fu X; Yao T; Zhou Y; Xu HA
Int J Exp Pathol; 2019 Aug; 100(4):234-243. PubMed ID: 31464029
[TBL] [Abstract][Full Text] [Related]
9. Knockdown of fbxl10/kdm2bb rescues chd7 morphant phenotype in a zebrafish model of CHARGE syndrome.
Balow SA; Pierce LX; Zentner GE; Conrad PA; Davis S; Sabaawy HE; McDermott BM; Scacheri PC
Dev Biol; 2013 Oct; 382(1):57-69. PubMed ID: 23920116
[TBL] [Abstract][Full Text] [Related]
10. Genomic distribution of CHD7 on chromatin tracks H3K4 methylation patterns.
Schnetz MP; Bartels CF; Shastri K; Balasubramanian D; Zentner GE; Balaji R; Zhang X; Song L; Wang Z; Laframboise T; Crawford GE; Scacheri PC
Genome Res; 2009 Apr; 19(4):590-601. PubMed ID: 19251738
[TBL] [Abstract][Full Text] [Related]
11. CHARGEd with neural crest defects.
Pauli S; Bajpai R; Borchers A
Am J Med Genet C Semin Med Genet; 2017 Dec; 175(4):478-486. PubMed ID: 29082625
[TBL] [Abstract][Full Text] [Related]
12. CHARGE syndrome protein CHD7 regulates epigenomic activation of enhancers in granule cell precursors and gyrification of the cerebellum.
Reddy NC; Majidi SP; Kong L; Nemera M; Ferguson CJ; Moore M; Goncalves TM; Liu HK; Fitzpatrick JAJ; Zhao G; Yamada T; Bonni A; Gabel HW
Nat Commun; 2021 Sep; 12(1):5702. PubMed ID: 34588434
[TBL] [Abstract][Full Text] [Related]
13. Functional Insights into Chromatin Remodelling from Studies on CHARGE Syndrome.
Basson MA; van Ravenswaaij-Arts C
Trends Genet; 2015 Oct; 31(10):600-611. PubMed ID: 26411921
[TBL] [Abstract][Full Text] [Related]
14. CHD7 targets active gene enhancer elements to modulate ES cell-specific gene expression.
Schnetz MP; Handoko L; Akhtar-Zaidi B; Bartels CF; Pereira CF; Fisher AG; Adams DJ; Flicek P; Crawford GE; Laframboise T; Tesar P; Wei CL; Scacheri PC
PLoS Genet; 2010 Jul; 6(7):e1001023. PubMed ID: 20657823
[TBL] [Abstract][Full Text] [Related]
15. Brg1 governs distinct pathways to direct multiple aspects of mammalian neural crest cell development.
Li W; Xiong Y; Shang C; Twu KY; Hang CT; Yang J; Han P; Lin CY; Lin CJ; Tsai FC; Stankunas K; Meyer T; Bernstein D; Pan M; Chang CP
Proc Natl Acad Sci U S A; 2013 Jan; 110(5):1738-43. PubMed ID: 23319608
[TBL] [Abstract][Full Text] [Related]
16. CHD7 functions in the nucleolus as a positive regulator of ribosomal RNA biogenesis.
Zentner GE; Hurd EA; Schnetz MP; Handoko L; Wang C; Wang Z; Wei C; Tesar PJ; Hatzoglou M; Martin DM; Scacheri PC
Hum Mol Genet; 2010 Sep; 19(18):3491-501. PubMed ID: 20591827
[TBL] [Abstract][Full Text] [Related]
17. CHD7 regulates craniofacial cartilage development via controlling HTR2B expression.
Breuer M; Rummler M; Singh J; Maher S; Zaouter C; Jamadagni P; Pilon N; Willie BM; Patten SA
J Bone Miner Res; 2024 May; 39(4):498-512. PubMed ID: 38477756
[TBL] [Abstract][Full Text] [Related]
18. A Novel N-terminal Region to Chromodomain in CHD7 is Required for the Efficient Remodeling Activity.
Lee E; Kang C; Purhonen P; Hebert H; Bouazoune K; Hohng S; Song JJ
J Mol Biol; 2021 Sep; 433(18):167114. PubMed ID: 34161779
[TBL] [Abstract][Full Text] [Related]
19. A functional assay to study the pathogenicity of CHD7 protein variants encountered in CHARGE syndrome patients.
Brajadenta GS; Bilan F; Gilbert-Dussardier B; Kitzis A; Thoreau V
Eur J Hum Genet; 2019 Nov; 27(11):1683-1691. PubMed ID: 31289371
[TBL] [Abstract][Full Text] [Related]
20. Mutation update on the CHD7 gene involved in CHARGE syndrome.
Janssen N; Bergman JE; Swertz MA; Tranebjaerg L; Lodahl M; Schoots J; Hofstra RM; van Ravenswaaij-Arts CM; Hoefsloot LH
Hum Mutat; 2012 Aug; 33(8):1149-60. PubMed ID: 22461308
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
